EUVIMEDEUVIMED entdecken
Crossref

Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase

Fouzia Nasim, Muppidi Shravan Kumar, Mallika Alvala, Insaf Ahmed Qureshi iD

The FEBS Journal · 2024

DOI: 10.1111/febs.17122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Fouzia Nasim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology & Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India. Hauptthemen laut MEDLINE: Leishmania donovani, Enzyme Inhibitors, Arginine-tRNA Ligase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: UoH-Institution of Eminence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aminoacylation by tRNA synthetase is a crucial part of protein synthesis and is widely recognized as a therapeutic target for drug development. Unlike the arginyl‐tRNA synthetases (ArgRSs) reported previously, here, we report an ArgRS of Leishmania donovani ( Ld ArgRS) that can follow the canonical two‐step aminoacylation process. Since a previously uncharacterized insertion region is present within its catalytic domain, we implemented the splicing by overlap extension PCR (SOE–PCR) method to create a deletion mutant (ΔIns‐ Ld ArgRS) devoid of this region to investigate its function. Notably, the purified Ld ArgRS and ΔIns‐ Ld ArgRS exhibited different oligomeric states along with variations in their enzymatic activity. The full‐length protein showed better catalytic efficiency than ΔIns‐ Ld ArgRS, and the insertion region was identified as the tRNA binding domain. In addition, a benzothiazolo‐coumarin derivative (Comp‐7j) possessing high pharmacokinetic properties was recognized as a competitive and more specific inhibitor of Ld ArgRS than its human counterpart. Removal of the insertion region altered the mode of inhibition for ΔIns‐ Ld ArgRS and caused a reduction in the inhibitor's binding affinity. Both purified proteins depicted variances in the secondary structural content upon ligand binding and thus, thermostability. Apart from the trypanosomatid‐specific insertion and Rossmann fold motif, Ld ArgRS revealed typical structural characteristics of ArgRSs, and Comp‐7j was found to bind within the ATP binding pocket. Furthermore, the placement of tRNA Arg near the insertion region enhanced the stability and compactness of Ld ArgRS compared to other ligands. This study thus reports a unique ArgRS with respect to catalytic as well as structural properties, which can be considered a plausible drug target for the derivation of novel anti‐leishmanial agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania donovaniEnzyme InhibitorsArginine-tRNA LigaseHumansCatalytic DomainProtozoan ProteinsAmino Acid SequenceAntiprotozoal Agents

Stichwörter der Autor:innen

arginyl‐tRNA synthetasebenzothiazolo‐coumarin derivativesnovel insertionpotent inhibitorstRNA‐binding domain

Substanzen

Enzyme InhibitorsArginine-tRNA LigaseProtozoan ProteinsAntiprotozoal Agents

Autor:innen und Institutionen

  • Department of Biotechnology & Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India.
  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Hyderabad, India.

ORCID-Profile: Insaf Ahmed Qureshi

Förderung

  • UoH-Institution of Eminence

Zitieren

APA

Nasim, F., Kumar, M. S., Alvala, M., & Qureshi, I. A. (2024). Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase. The FEBS Journal. https://doi.org/10.1111/febs.17122

Vancouver

Nasim F, Kumar MS, Alvala M, Qureshi IA. Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase. The FEBS Journal. 2024. doi:10.1111/febs.17122

BibTeX
@article{Nasim2024,
  author = {Nasim, Fouzia and Kumar, Muppidi Shravan and Alvala, Mallika and Qureshi, Insaf Ahmed},
  title = {Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase},
  journal = {The FEBS Journal},
  year = {2024},
  doi = {10.1111/febs.17122}
}
Kostenlos starten →